The Patent Finder

Terms ending in 2030

Ucb Pharma S.A.

Every in-force patent on Ucb Pharma S.A.'s record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,044,0618-Alkynylxanthines and Derivatives
In force
 · High confidence
Rheinische Friedrich-Wilhelms-Universitaet BonnIn forceHigh confidence
US 8,460,712Prolonged Release Formulations Comprising an 2-Oxo-1-Pyrrolidine Derivate
In force
 · Medium confidence
Ucb Biopharma SPRLIn forceMedium confidence
US 9,476,081Method for Producing Protein
In force
 · High confidence
Ucb Biopharma SPRLIn forceHigh confidence
US 8,563,036Pharmaceutical Compositions Comprising Brivaracetam
In force
 · High confidence
Ucb Biopharma SPRLIn forceHigh confidence
US 9,428,570Antibody Molecules Having Specificity for Human OX40
In force
 · High confidence
Ucb Biopharma SPRLIn forceHigh confidence
US 9,394,361Isolated DNA Sequences Encoding, and Methods for Making,antibody Molecules Having Binding Specificity for Human IL-13
In force
 · High confidence
Ucb Biopharma SPRLIn forceHigh confidence
US 9,315,565Method for Producing Protein
In force
 · High confidence
Ucb Biopharma SPRLIn forceHigh confidence
US 10,729,653Pharmaceutical Compositions Comprising 2-Oxo-1-Pyrrolidine Derivatives
In force
 · Medium confidence
Ucb Developed Brands SRLIn forceMedium confidence
US 8,946,476Novel Process for the Preparation of Amino Acid Derivatives
In force
 · High confidence
Ucb Pharma GmbHIn forceHigh confidence
US D755,956Cassette Device for Administering Medication
In force
 · High confidence
Ucb Pharma S.A.In forceHigh confidence
11 more term ends in 2030 · Pro
10 of 21 patents shown. Soonest term end first, then patent number.
Pro members see all 21.
Upgrade to Pro
11 of these are in force and held by Ucb Pharma S.A..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited